Articles

Response to "DDT and Urogenital Malformations in Newborn Boys in a Malarial Area"

Richard Tren & Donald Roberts et al | 09 Apr 2010 | British Journal of Urology International

Richard Tren and Donald Roberts et al respond to the study by Bornman et al entitled "DDT and urogenital malformations in newborn boys in a malarial area" published in BJUI in October 2009.

About Those Malaria Goals

Richard Tren & Donald Roberts | 08 Apr 2010 | Wall Street Journal

World Marlaria Day is coming up later this month. So as public health groups gather to bring attention to the mosquito-borne disease that kills almost one million people annually, and inflicts fever and pain on some 500 million more, expect many calls for its eradication.

Quality Chemical Industries Ltd in Compliance with WHO GMP

None | 12 Mar 2010 | Africa Fighting Malaria

Quality Chemical Industries Limited of Uganda has been found to be operating in compliance with WHO Good Manufacturing Practices. This is an impressive start for local pharmaceutical manufacturing in Africa. However, there are still some big hurdles to clear: will they get WHO prequalification or SRA approval for a particular drug, after which they would be eligible for donor funding, and will they be able to produce at a low enough price to be competitive?

Letter to Andrew Gwynne MP, sponsor of the Private Member's Bill: Debt Relief (Developing Countries)

None | 25 Feb 2010 | Free Market Foundation

We write to you as a group of experts dedicated to alleviating poverty. We share your noble
goal of freeing millions of impoverished people from the weight of stifling debt and
improving their living standards. You deserve great credit for seeking solutions to these
hugely important issues.

Killer drugs

Jasson Urbach & Richard Tren | 03 Feb 2010 | Health Policy Unit

A consignment of fake anti-malaria drugs worth an estimated N10 million (approximately R500,000) was seized recently by the Nigerian National Agency of Food and Drugs Administration and Control (NAFDAC). Fake drugs do not cure patients' ailments. Usually they contain little if any active ingredient and often contain chemicals that not only fail to treat the underlying ailment but also cause direct harm to the patient.

DDT and Malaria Prevention

Richard Tren & Donald Roberts | 01 Jan 2010 | Environmental Health Perspectives

In his commentary "Global Status of DDT and Its Alternatives for Use in Vector Control to Prevent Disease," van den Berg (2009) raised concerns about the impact of DDT and its derivates on human health, in spite of the fact that DDT has been used widely for seven decades and no properly replicated and confirmed study has found any specific human health harm.

Drug procurement, the Global Fund and misguided competition policies

Richard Tren , Kimberly Hess & Roger Bate | 22 Dec 2009 | Malaria Journal

In an effort to increase competition and decrease price, the Global Fund to Fight AIDS, Tuberculosis and Malaria recently began asking some grant recipients to use international competitive bidding processes for certain drug purchases.

Opinion: Misguided policies keep life-saving drugs out of reach

Richard Tren & James Taylor | 17 Dec 2009 | GlobalPost

Malaria is a preventable and curable disease that kills nearly 1 million people, mostly children, every year. This disease continues to kill in large part because so many poor people living in Africa lack access to safe, effective and affordable medicines.

'Don't put the south on the road to permanent poverty'

Richard Tren & Franklin Cudjoe | 05 Dec 2009 | Bangkok Post

As diplomats and delegates from the around the world gather in Copenhagen this month for a global climate change summit, a major rift is developing between rich and poor countries. The question is whether or not developing nations should be permitted to harness their natural resources to lift their people out of poverty.

AFM Interview with Lawrence Cowper

None | 10 Nov 2009 | Africa Fighting Malaria

Lawrence Cowper is a vector-borne disease specialist who has worked in public health in the United States and developing countries since 1951. He was Chief of the environmental health section for Guam between 1955 and 1959, after which he was appointed Chief Malaria Advisor to Nepal, where during the 1960s he built-up a highly successful malaria control program.